Radana Bhaskara Finance Tbk. vs Merck Tbk. — how do they compare? Radana Bhaskara Finance Tbk. trades at Rp88 (market cap 562.65B, 595.8K 24h volume), while Merck Tbk. trades at Rp3,860 (market cap 1.7T, 34.5K 24h volume). The key difference: Merck Tbk. is far larger — about 3× Radana Bhaskara Finance Tbk.'s market cap, and Radana Bhaskara Finance Tbk. is more actively traded (595.8K versus 34.5K). Which is the better fit depends on your goals.
| HDFA | MERK | |
|---|---|---|
Market Cap | 562.65B | 1.7T |
Volume | 595.8K | 34.5K |
Lot | 5.96K | 345 |
Turnover | 53.61M | 132.56M |
Average Price | 89.99 | 3,842.35 |
Value | 53.61M | 132.56M |
Indicative Equilibrium Price | 100 | 3,850 |
Indicative Equilibrium Volume | 86.6K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT HD Finance (the company) was incorporated under the name of PT Indonesia Lease Corporation base on notarial deed No.41 of Mr FA Tumbuan, S.H, dated 20 Sep, 1972. The Company's name has been changed from PT HD Finance Tbk to PT Radana Bhaskara Finance Tbk based on the Notarial Deed No. 136 dated May 21, 2014 of Jimmy Tanal, S.H., M.Kn.
Read more on HDFA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →